Cite Filings / SLS / 0001104659-26-130132
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

SELLAS Life Sciences Group, Inc. · Filed 2026-11-19 · Acc 0001104659-26-130132

Documents 1

  • 424B5 Prospectus , tm2629996d2_424b5.htm

Around this filing

  • 2026-11-20 4 CFO sold 3,831 shares at $19.18 ($73,471)
  • 2026-11-20 4 SVP, Chief Development Officer sold 6,933 shares at $19.18 ($132,961)
  • 2026-11-20 4 President and CEO sold 26,606 shares at $19.18 ($510,250)
  • 2026-11-20 8-K Material agreement · Other events
  • 2026-11-19 424B5 Prospectus
  • 2026-11-17 424B5 Prospectus
  • 2026-11-17 8-K Regulation FD disclosure · Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2629996d2_424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…